Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2026-01-02 @ 12:28 AM
Study NCT ID:
NCT00859469
Status:
COMPLETED
Last Update Posted:
2019-10-30
First Post:
2009-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma
Sponsor:
Columbia University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-04
Start Date Type:
None
Primary Completion Date:
2009-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03
Completion Date Type:
ACTUAL
First Submit Date:
2009-03-09
First Submit QC Date:
None
Study First Post Date:
2009-03-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-01-20
Results First Submit QC Date:
None
Results First Post Date:
2012-02-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-15
Last Update Post Date:
2019-10-30
Last Update Post Date Type:
ACTUAL